American Health Packaging is recalling 15,386 cartons of Anastrozole (generic Arimidex) 1mg tablets, which are used to treat breast cancer. This voluntary recall was initiated because of a failure in the facility's cleaning procedures, which could lead to cross-contamination with other drug products. These prescription tablets were distributed nationwide in unit-dose blister packs of 30 tablets per carton. No specific injuries or illnesses have been reported at this time, but the manufacturer is recalling specific lots to ensure patient safety.
A failure in the cleaning process during manufacturing created a risk that residues from other medications could contaminate these tablets. Consuming a medication contaminated with an unintended drug substance can lead to adverse reactions or reduced effectiveness of the primary treatment.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.